MAMarcello Holanda de Andrade

Marcello Holanda de Andrade

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marcello Holanda de Andrade has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perfil clínico e epidemiológico de pacientes com migrânea tratados na clínica de neurologia de um hospital universitário

    by Marcello Holanda de Andrade, Raimundo Nonato Marques Filho, Saula Maria de Lira Ribeiro, Lucas Soares Brandão Barros, Danielle Barcellos Morais, Lucas Cavalcanti de Sá Roriz, Yasmin Lara Lopes de Moura, Michelly Gomes da Silva, Franciluz Morais Bispo

    O presente estudo buscou avaliar o perfil clínico e epidemiológico dos pacientes com migrânea atendidos no ambulatório de neurologia de um Hospital Universitário. Tratou-se de um estudo quantitativo, descritivo, observacional e retrospectivo com pacientes adultos diagnosticados com migrânea, atendidos de 1º de janeiro a 31 de dezembro de 2021. Informações sociodemográficas e clínicas foram coletadas dos prontuários. Foram incluídos 247 pacientes, predominantemente mulheres (93,5%), com idade média de 43,7 anos, casados (48,6%), sem histórico familiar (56,0%) ou tratamento prévio (57,7%). Cerca de 74,9% relataram comorbidades, sendo HAS (26,2%) e transtornos psiquiátricos (12,6%) os mais prevalentes. Houve associação significativa entre a quantidade de dias de migrânea por mês e a presença de comorbidades (p< 0,05) e entre migrânea crônica e comorbidades (OR 2,65). Esta pesquisa caracterizou o perfil clínico e epidemiológico dos pacientes, confirmando que comorbidades estão associadas à cronificação da migrânea e interferem nas atividades cotidianas.

  • Open Access

    Long COVID: neurological manifestations - an updated narrative review

    by José Wagner Leonel Tavares-Júnior, Gabriella Cunha Vieira Ciurleo, Alissa Moura Formiga, Thais de Maria Frota Vasconcelos, Marcello Holanda de Andrade, Werbety Lucas Queiroz Feitosa, Antônio Alves Sobreira-Neto, Chiara Gübel Portugal, Lorenzo Marinho Morais, Samuel Cavalcante Marinho, et al.

    Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.


  • Open Access

    Fahr’s Syndrome: A Case Report

    by Ana Karoline da Costa Monteiro, Paulo Filho Soares Marcelino, Marcello Holanda de Andrade, Rairis Barbosa Nascimento, Marx Lincoln Lima de Barros Araújo, Samuel Pinheiro da Silva

    Context: Fahr’s syndrome is a clinical entity of primary or secondary causes characterized by neurological and/or psychiatric symptoms associated with abnormal calcifications in basal ganglia, cerebellum and cerebral cortex. Case report: G.M.A, female, 49 years-old, presented athetosis in the distal extremity of the right upper limb (RUL) in December 2020, without seeking for medical help. Known to be diabetic, hypertensive and with diastolic heart failure (HF), in February 2021 she presented decompensated HF associated with worsening of involuntary movements in the RUL. During investigation, abnormalities in serum levels of parathormone (PTH) and calcium were observed, in addition to bilateral calcifications in basal ganglia and thalamus in brain computed tomography (CT) without contrast. In March 2021, she was admitted to the University Hospital of the Federal University of Piauí, with maintenance of athetosis at the distal extremity of the RUL, in addition to oromandibular dyskinesia. Laboratory profile compatible with primary hypoparathyroidism and new brain CT without contrast with calcifications in basal ganglia and pulvinar of the thalamus, bilaterally, were confirmed. Intravenous calcium replacement and use of calcitriol were performed, with partial clinical improvement. Conclusions: Fahr’s syndrome is characterized by the presence of movement disorders (with highlights for parkinsonism and athetosis) and psychiatric symptoms (depression most commonly). Possible etiologies are primary (genetic) and secondary (mainly idiopathic or secondary hypoparathyroidism). Classic finding of symmetrical calcifications in base nuclei is seen on brain CT. Treatment is symptomatic and control of the underlying disease.